Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comprehensive/tertiary care for headache: a 6-month outcome study.

J R Saper1, A E Lake, S F Madden

  • 1Michigan Head-Pain and Neurological Institute, Ann Arbor, MI 48104, USA.

Headache
|December 23, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer.

Breast cancer research and treatment·2021
Same author

Expression of anaesthetic and analgesic drug target genes in excised breast tumour tissue: Association with clinical disease recurrence or metastasis.

PloS one·2017
Same author

The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation.

BMC cancer·2017
Same author

ADAM-17: a novel therapeutic target for triple negative breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Medication overuse headache: type I and type II.

Cephalalgia : an international journal of headache·2006
Same author

Medication overuse headache (MOH) is a biobehavioural disorder.

Cephalalgia : an international journal of headache·2005
Same journal

Biochemical profiling and symptomatology of androgen deficiency in males with cluster headache: A prospective case-control study.

Headache·2026
Same journal

Thiamine deficiency in patients with chronic migraine: A case-control study.

Headache·2026
Same journal

Potential association of cluster headache with certain COVID-19 vaccines: An assessment from the pharmacovigilance databases.

Headache·2026
Same journal

Potential role of tirzepatide, a dual GLP-1 and GIP receptor agonist, for preventive treatment of migraine: A case series.

Headache·2026
Same journal

Adverse childhood experiences, migraine, and adverse pregnancy outcomes among teenage mothers.

Headache·2026
Same journal

Weight loss with atogepant in the long-term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open-label, 156-week extension study.

Headache·2026
See all related articles

Comprehensive headache treatment significantly reduced headache frequency and improved patient function and work performance within six months. This multidisciplinary approach proved cost-effective for severe, refractory headache disorders.

Area of Science:

  • Neurology
  • Public Health
  • Health Economics

Background:

  • Limited data exists on the efficacy of comprehensive, multidisciplinary treatment centers for severe, refractory headache disorders.
  • Assessing program-wide outcomes for such centers is crucial for understanding treatment effectiveness.

Purpose of the Study:

  • To evaluate the program-wide outcomes of a comprehensive headache center over the initial six months of treatment.
  • To assess improvements in headache frequency, severity, and related functional impairments.

Main Methods:

  • Prospective data collection over a 2-year period from new patients at a comprehensive headache center.
  • Patients completed monthly questionnaires on headache frequency/severity; a 6-month follow-up was mailed.
  • Data analyzed included headache metrics, emergent care visits, work impairment, and treatment satisfaction.

Related Experiment Videos

Main Results:

  • Mean headache frequency decreased from 5.30 to 3.45 days/week (P<.00001).
  • Severe headaches reduced by 56% (median 67%); emergent care visits dropped from 4.39 to 1.67 (P<.00001).
  • Work impairment and days incapacitated significantly decreased, with high treatment satisfaction (89%) and overall Goal Attainment score of 72%.

Conclusions:

  • Comprehensive headache treatment led to significant improvements in pain control, functioning, and work performance within six months.
  • The findings support the cost-effectiveness of matching intensive treatment to complex, refractory headache cases.
  • Even with limited medical visits, significant improvements were observed, highlighting the value of specialized care.